吲哚菁绿荧光引导对比常规腹腔镜肝切除治疗肝细胞癌:倾向评分匹配时间-事件Meta分析
该系统综述与Meta分析纳入6项回顾性倾向评分匹配研究共686例肝细胞癌患者,比较吲哚菁绿荧光引导与常规腹腔镜肝切除。结果显示吲哚菁绿组死亡风险较低(HR 0.67,95%CI 0.46-0.99),中转开腹率较低(RR 0.15,95%CI 0.04-0.66),术后感染率较低(RR 0.33,95%CI 0.14-0.83),但中转与感染结果基于少量研究和事件,属探索性。手术时间、住院时间、R0切除、复发相关结局及多数术后并发症无显著差异,证据确定性极低。
要点
- 吲哚菁绿引导组死亡风险较低(HR 0.67,95%CI 0.46-0.99),但证据确定性极低。
- 中转开腹率(RR 0.15,95%CI 0.04-0.66)和术后感染率(RR 0.33,95%CI 0.14-0.83)较低,属探索性发现。
- 手术时间、住院时间、R0切除、复发相关结局及多数并发症无显著差异。
核心结论
- 当前证据未显示吲哚菁绿引导腹腔镜肝切除具有一致的临床获益或优越性。
- 虽观察到死亡风险、中转开腹和术后感染较低,但属探索性发现,需标准化方案和前瞻性研究验证。
研究设计与样本
- 符合PRISMA的系统综述与Meta分析,检索PubMed、Scopus、Web of Science和Cochrane CENTRAL至2026年6月。
- 纳入6项回顾性倾向评分匹配研究,共686例成人肝细胞癌患者,比较吲哚菁绿引导与常规腹腔镜肝切除。
- 采用随机效应模型合并风险比、风险比和均数差,并用GRADE评估证据确定性。
主要发现
- 吲哚菁绿引导组死亡风险较低(HR 0.67,95%CI 0.46-0.99)。
- 吲哚菁绿引导组中转开腹率较低(RR 0.15,95%CI 0.04-0.66),但基于少量研究和事件。
- 吲哚菁绿引导组术后感染率较低(RR 0.33,95%CI 0.14-0.83),同样属探索性。
- 术中出血量较低,但异质性大限制该估计。
- 手术时间、住院时间、R0切除、复发相关结局及多数术后并发症无显著差异。
关键数值与推荐
- 死亡风险HR 0.67(95%CI 0.46-0.99)。
- 中转开腹RR 0.15(95%CI 0.04-0.66)。
- 术后感染RR 0.33(95%CI 0.14-0.83)。
- 证据确定性极低,存在严重偏倚风险、方案异质性和残留混杂。
临床怎么用
- 目前不宜将吲哚菁绿引导腹腔镜肝切除作为肝细胞癌的标准常规推荐。
- 临床决策时应权衡其潜在获益与证据不确定性,并关注吲哚菁绿方案标准化。
- 鼓励开展设计良好的前瞻性研究以验证其围术期和肿瘤学结局。
局限性
- 仅纳入回顾性倾向评分匹配研究,存在残留混杂和选择偏倚。
- 中转开腹和术后感染结果基于少量研究和事件,属探索性。
- 吲哚菁绿方案异质性大,术中出血量估计异质性显著。
- 证据确定性极低,限制结论可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indocyanine green fluorescence imaging is increasingly used during laparoscopic hepatectomy to improve intraoperative visualization and surgical precision; however, its effect on perioperative and oncologic outcomes in hepatocellular carcinoma remains uncertain. METHODS: We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review and meta-analysis of propensity score-matched studies comparing indocyanine green guided with conventional laparoscopic hepatectomy in adults with hepatocellular carcinoma. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched from inception to June 2026. Random-effects models were used to pool hazard ratios, risk ratios, and mean differences. Certainty of evidence was assessed using Grading of Recommendations Assessment, Development, and Evaluation. RESULTS: Six retrospective propensity score-matched studies involving 686 patients were included. Indocyanine green-guided laparoscopic hepatectomy was associated with a lower hazard of death (hazard ratio, 0.67; 95% confidence interval, 0.46-0.99), fewer conversions to open surgery (risk ratio, 0.15; 95% confidence interval, 0.04-0.66), and a lower postoperative infection rate (risk ratio, 0.33; 95% confidence interval, 0.14-0.83). However, the conversion and infection findings were based on few studies and events and should be considered exploratory. Intraoperative blood loss was lower, but substantial heterogeneity limited this estimate. No significant differences were observed in operative time, hospital stay, R0 resection, recurrence-related outcomes, or most postoperative complications. The evidence was limited by serious risk of bias, protocol heterogeneity, and very low certainty. CONCLUSION: Current evidence does not demonstrate a consistent clinical benefit or superiority of indocyanine green-guided laparoscopic hepatectomy. Although associations with a lower hazard of death, conversion to open surgery, and postoperative infection were observed, these findings are exploratory because of the retrospective evidence, sparse events, residual confounding, and substantial heterogeneity in indocyanine green protocols. Standardized protocols and well-designed prospective studies are required.
引用
- Albashier, Mohkam, Saleh, et al. Indocyanine green fluorescence-guided versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: A propensity score-matched time-to-event meta-analysis. Surgery. 2026. PMID: 42945930. doi:10.1016/j.surg.2026.110678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。